Article
Effects of gabexate mesylate on the gut microbiota and metabolomics in rats with sepsis
2022-05-17
Abstract excerpt
<h4>Background: </h4> Sepsis develops in millions of people worldwide annually. Only 30%–40% of septic shock cases have positive microbial culture results [1] . Currently, there is no clear early diagnostic marker for sepsis. The gut microbiota and metabolomics significantly change in sepsis. Previous studies have reported that gabexate mesylate (GM) could alleviate liver and lung injury and high inflammatory stat...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 56daba1e-7670-5d28-a3e7-2fa0568fcc08
- DOI
- 10.21203/rs.3.rs-1630217/v1
